Frauenheilkunde up2date, Inhaltsverzeichnis Frauenheilkunde up2date 2014; 8(2): 86-90DOI: 10.1055/s-0033-1357898 Forum Georg Thieme Verlag KG Stuttgart · New York Finanzierung von komplementären und alternativen Therapieverfahren Thomas Hildebrandt , Carolin C. Hack , Michael P. Lux Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Volltext Referenzen Literatur 1 GKV-Kennzahlen. Berlin: GKV – Spitzenverband; 2013. http://www.gkv-spitzenverband.de/presse/zahlen_und_grafiken/gkv_kennzahlen/gkv_kennzahlen.jsp%23lightbox Stand: 15.12.2013 2 Spielberg P. Schul- und Komplementärmedizin: Miteinander statt nebeneinander. Dtsch Arztebl International 2007; 104: A-3148 3 Kennedy DA, Hart J, Seely D. Cost effectiveness of natural health products: a systematic review of randomized clinical trials. Evid Based Complement Alternat Med 2009; 6: 297-304 4 Spinks J, Hollingsworth B. Are the economics of complementary and alternative medicine different to conventional medicine?. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 1-4 5 Herman PM, Poindexter BL, Witt CM, Eisenberg DM. Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations. BMJ Open 2012; 2 pii: e001046 6 Bischoff M. Phytotherapie: Beliebt und effektiv. Dtsch Arztebl International 2012; 109: A-221-A-221 7 Lang CJG. Homöopathie: Hokuspokus. Dtsch Arztebl International 2010; 107: A-2506-A-2506 8 Witt CM. Komplementärmedizin: Weitere Forschung ist die Basis für Integration in die Versorgung. Dtsch Arztebl International 2009; 106: A-1786 9 Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ 2012; 13: 769-776 10 Lux MP, Fasching PA, Löhberg CR et al. Health services research and health economy – quality care training in gynaecology, with focus on gynaecological oncology. Geburtsh Frauenheilk 2011; 71: 1046-1055 11 Coulter ID, Herman PM, Nataraj S. Economic analysis of complementary, alternative, and integrative medicine: considerations raised by an expert panel. BMC Complement Altern Med 2013; 13: 191 12 Kim N, Yang B, Lee T et al. An economic analysis of usual care and acupuncture collaborative treatment on chronic low back pain: a Markov model decision analysis. BMC Complement Altern Med 2010; 25: 74 13 Witt CM, Jena S, Selim D et al. Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol 2006; 164: 487-496 14 Ratcliffe J, Thomas KJ, MacPherson H et al. A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis. BMJ 2006; 333: 626 15 Studer HP, Busato A. Comparison of Swiss basic health insurance costs of complementary and conventional medicine. Forsch Komplementmed 2011; 18: 315-320 16 Regan KS, Wambogo EA, Haggans CJ. NIH and USDA funding of dietary supplement research, 1999–2007. J Nutr 2011; 141: 1-3 17 Breitkreutz F. Erstattung komplementärer Krebstherapie. Anspruch und Wirklichkeit in der aktuellen Rechtsprechung. 16. Internationaler GfbK-Kongress. Heidelberg; 2013. http://www.dr-breitkreutz.de/images/Praesentationen_pdf-Dateien/2013-05-04_RA_Dr_Breitkreutz_Erstattung_Komplementronkologie.pdf Stand: 07.05.2013